NCT03967847

Oral Ketorolac for Arthroscopic Rotator Cuff Repair

Oral Ketorolac as an Adjuvant Agent for Postoperative Pain Control Following Arthroscopic Rotator Cuff Repair

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 44 (actual)
• Sponsor: University Hospitals Cleveland Medical Center · Academic / Other
• Sex: All
• Age: 18 Years – 89 Years
• Healthy volunteers: Not accepted

Summary

1. The investigators aim to examine the use of IV and oral ketorolac as an adjunctive agent to the standard of care pain protocol for postoperative pain control following arthroscopic rotator cuff repair. 2. The investigators hypothesize that the use of IV and oral ketorolac in addition to the standard of care pain protocol will reduce postoperative opioid consumption following arthroscopic rotator cuff repair.

Conditions

• Rotator Cuff Tear
• Postoperative Pain

Interventions

Type	Name	Description
DRUG	Ketorolac	Oral Ketorolac

Timeline

• Start date: 2019-02-11
• Primary completion: 2020-10-14
• Completion: 2021-05-17
• First posted: 2019-05-30
• Last updated: 2022-05-10
• Results posted: 2022-05-10

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study